Phase 1 Castration-Resistant Prostate Cancer (CRPC) Clinical Trials

3 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–3 of 3 trials

Recruiting

Phase 1Phase 2

A Study to Investigate the Safety, Pharmacokinetics, and Preliminary Efficacy of IDE574 Therapy in Adult Participants With Advanced Solid Tumors

Non-small Cell Lung Cancer (NSCLC)Castration-Resistant Prostate Cancer (CRPC)ER+, HER 2- Breast Cancer+1 more

IDEAYA Biosciences160 enrolled6 locationsNCT07540572

Recruiting

Phase 1Phase 2

177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors

Colorectal, CancerOvarian CancerCervical Cancer+7 more

Radiopharm Theranostics, Ltd61 enrolled4 locationsNCT07189871

Recruiting

Phase 1

Novel ACK1 Inhibitor (R)-9b in Patients With Prostate Cancer

Metastatic Castration-resistant Prostate Cancer (CRPC)Metastatic Castration-Resistant Prostate Carcinoma

TechnoGenesys, Inc.40 enrolled1 locationNCT06705686